173 related articles for article (PubMed ID: 30154718)
1. Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival.
Wang PF; Meng Z; Song HW; Yao K; Duan ZJ; Yu CJ; Li SW; Yan CX
Front Pharmacol; 2018; 9():886. PubMed ID: 30154718
[No Abstract] [Full Text] [Related]
2. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas.
Zhang ZY; Zhan YB; Zhang FJ; Yu B; Ji YC; Zhou JQ; Bai YH; Wang YM; Wang L; Jing Y; Duan WC; Sun C; Sun T; Zhao HB; Li K; Wang WQ; Li RY; Sun HW; Zhai G; Wang SK; Wei XT; Yang B; Yan DM; Liu XZ; Wang WW
Aging (Albany NY); 2019 Aug; 11(16):6252-6272. PubMed ID: 31444316
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Inflammatory Blood Markers in Diagnosis of Glioma and IDH Status.
Sharma G; Jain SK; Sinha VD
J Neurosci Rural Pract; 2021 Jan; 12(1):88-94. PubMed ID: 33551616
[No Abstract] [Full Text] [Related]
6. Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas.
Han S; Qu FW; Wang PF; Liu YX; Li SW; Yan CX
Front Surg; 2022; 9():803237. PubMed ID: 35495765
[TBL] [Abstract][Full Text] [Related]
7. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.
Wang PF; Song HW; Cai HQ; Kong LW; Yao K; Jiang T; Li SW; Yan CX
Oncotarget; 2017 Jul; 8(30):50117-50123. PubMed ID: 28223536
[TBL] [Abstract][Full Text] [Related]
8. Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers.
Yang C; Lan T; Wang Y; Huang WH; Li SM; Li J; Li FP; Li YR; Wang ZF; Li ZQ
Front Oncol; 2022; 12():716295. PubMed ID: 35719947
[TBL] [Abstract][Full Text] [Related]
9. The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma.
Chen F; Chao M; Huang T; Guo S; Zhai Y; Wang Y; Wang N; Xie X; Wang L; Ji P
Front Oncol; 2022; 12():1055783. PubMed ID: 36483052
[TBL] [Abstract][Full Text] [Related]
10. Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study.
Wang PF; Zhang J; Cai HQ; Meng Z; Yu CJ; Li SW; Wan JH; Yan CX
J Cancer; 2019; 10(23):5654-5660. PubMed ID: 31737102
[TBL] [Abstract][Full Text] [Related]
11. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
12. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio, and prognostic nutritional index for patients with glioma: A meta-analysis.
Liu M; Wang L
Medicine (Baltimore); 2020 Jul; 99(27):e20927. PubMed ID: 32629692
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of preoperative albumin to globulin ratio for predicting clinical outcome in patients with high-grade gliomas.
Liu J; Zhan YB; Zhang FJ; Yu B; Duan WC; Wang WW; Wang L; Yang B; Zhang ZY
Transl Cancer Res; 2019 Sep; 8(5):1727-1733. PubMed ID: 35116922
[TBL] [Abstract][Full Text] [Related]
16. Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma.
Xu WZ; Li F; Xu ZK; Chen X; Sun B; Cao JW; Liu YG
Onco Targets Ther; 2017; 10():725-733. PubMed ID: 28223828
[TBL] [Abstract][Full Text] [Related]
17. Blood-based biomarkers: diagnostic value in brain tumors (focus on gliomas).
Yang Y; Hu F; Wu S; Huang Z; Wei K; Ma Y; Ou-Yang Q
Front Neurol; 2023; 14():1297835. PubMed ID: 37936915
[TBL] [Abstract][Full Text] [Related]
18. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram.
He Q; Li L; Ren Q
Front Oncol; 2021; 11():671811. PubMed ID: 34055639
[TBL] [Abstract][Full Text] [Related]
20. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
